Fresenius Loses Diprivan IP Suit Against Actavis, Dr. Reddy's
Fresenius Kabi USA LLC has lost its bid to show that Actavis Inc. and India-based Dr. Reddy's Laboratories Ltd. infringed four of Fresenius' patents by attempting to market a generic form...To view the full article, register now.
Already a subscriber? Click here to view full article